Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Deepa S. Mandlik & Satish K. Mandlik. (2020) New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacology and Immunotoxicology 42:6, pages 521-544.
Read now
Read now
Giancarlo Marone, Maria Rosaria Galdiero, Antonio Pecoraro, Valentina Pucino, Gjada Criscuolo, Maria Triassi & Gilda Varricchi. (2019) Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Expert Opinion on Investigational Drugs 28:1, pages 73-84.
Read now
Read now
Articles from other publishers (17)
Hugo Farne, Nicholas Glanville, Nicholas Johnson, Tata Kebadze, Julia Aniscenko, Eteri Regis, Jie Zhu, Maria-Belen Trujillo-Torralbo, Onn Min Kon, Patrick Mallia, A Toby Prevost, Michael R Edwards, Sebastian L Johnston, Aran Singanayagam & David J Jackson. (2022) Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial. Thorax 77:10, pages 950-959.
Crossref
Crossref
Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. van der Spek, Hari S. Sharma & Saurabh Satija. (2022) Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions 365, pages 110050.
Crossref
Crossref
Mark H. Moss, Njira L. Lugogo, Mario Castro, Nicola A. Hanania, Andrea Ludwig-Sengpiel, Dinesh Saralaya, Rafal Dobek, Iñigo Ojanguren, Ivan Vyshnyvetskyy, Jean-Marie Bruey, Robin Osterhout, Cindy-ann Tompkins, Karen Dittrich, Kartik Raghupathi & Hector Ortega. (2022) Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma. Chest 162:2, pages 297-308.
Crossref
Crossref
David J. Jackson & James E. Gern. (2022) Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations. The Journal of Allergy and Clinical Immunology: In Practice 10:3, pages 673-681.
Crossref
Crossref
Yuko Abe, Yasuhiko Suga, Kiyoharu Fukushima, Hayase Ohata, Takayuki Niitsu, Hiroshi Nabeshima, Yasuharu Nagahama, Hiroshi Kida & Atsushi Kumanogoh. (2021) Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma. International Journal of Molecular Sciences 23:1, pages 83.
Crossref
Crossref
Andrew Menzies-Gow, William W. Busse, Mario Castro & David J. Jackson. (2021) Prevention and Treatment of Asthma Exacerbations in Adults. The Journal of Allergy and Clinical Immunology: In Practice 9:7, pages 2578-2586.
Crossref
Crossref
Andrew P. Hearn, Brian D. Kent & David J. Jackson. (2020) Biologic treatment options for severe asthma. Current Opinion in Immunology 66, pages 151-160.
Crossref
Crossref
Koichiro Asano, Hironori Sagara, Masakazu Ichinose, Masayuki Hirata, Akihiro Nakajima, Hector Ortega & Yuji Tohda. (2020) A Phase 2a Study of DP2 Antagonist GB001 for Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:4, pages 1275-1283.e1.
Crossref
Crossref
Oyebola O. Oyesola, Carolina Duque, Linda C. Huang, Elisabeth M. Larson, Simon P. Früh, Lauren M. Webb, Seth A. Peng & Elia D. Tait Wojno. (2020) The Prostaglandin D2 Receptor CRTH2 Promotes IL-33–Induced ILC2 Accumulation in the Lung. The Journal of Immunology 204:4, pages 1001-1011.
Crossref
Crossref
Hector Ortega, Mary Fitzgerald, Kartik Raghupathi, Cindy‐ann Tompkins, Jinshan Shen, Karen Dittrich, Caroline Pattwell & Dave Singh. (2019) A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild‐to‐moderate asthma. Clinical & Experimental Allergy 50:2, pages 189-197.
Crossref
Crossref
Nicole Akar-Ghibril, Ahmad Salaheddine Naja & Wanda Phipatanakul. 2020. Severe Asthma in Children and Adolescents. Severe Asthma in Children and Adolescents
133
155
.
Seyyed Shamsadin Athari. (2019) Targeting cell signaling in allergic asthma. Signal Transduction and Targeted Therapy 4:1.
Crossref
Crossref
James D. Nolin, Ryan C. Murphy, Michael H. Gelb, William A. Altemeier, William R. HendersonJr.Jr. & Teal S. Hallstrand. (2019) Function of secreted phospholipase A2 group-X in asthma and allergic disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1864:6, pages 827-837.
Crossref
Crossref
Mehtap Haktanir Abul & Wanda Phipatanakul. (2019) Severe asthma in children: Evaluation and management. Allergology International 68:2, pages 150-157.
Crossref
Crossref
Christian Domingo, Oscar Palomares, David A. Sandham, Veit J. Erpenbeck & Pablo Altman. (2018) The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation. Respiratory Research 19:1.
Crossref
Crossref
Pascale Kippelen, Sandra D. Anderson & Teal S. Hallstrand. (2018) Mechanisms and Biomarkers of Exercise-Induced Bronchoconstriction. Immunology and Allergy Clinics of North America 38:2, pages 165-182.
Crossref
Crossref
Linda Zhu, Christina E. Ciaccio & Thomas B. Casale. (2018) Potential new targets for drug development in severe asthma. World Allergy Organization Journal 11, pages 30.
Crossref
Crossref